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Platinum Trimethyl Bipyridyl Thiolates – New, Tunable, Red- to 
Near IR Emitting Luminophores for Bioimaging Applications  
Harriet L. Steel,a Sarah L. Allinson,a Jane Andre,a Michael P. Coogan,b* and James A. Plattsc
Synthetic, spectroscopic, computational and biological imaging 
studies of platinum trimethyl bipyridyl thiolate complexes of the 
general formula [PtMe3(bpy)SR] reveal these to be easily 
accessed, tunable bioimaging agents which feature an unusual 
σ−pi*Inter-Ligand Charge Transfer (ILCT) transition, and in some 
cases emit into the Near infra-red (NIR). 
Platinum (IV) trimethyl iodide exists as a cubic tetramer which 
reacts with a large range of ligands to give stable octahedral 
complexes of the general formula fac-[Pt(Me)3(L)2I] which have 
been extensively studied.1 In the case of chelating bis-heterocyclic 
ligands such as bipyridine, the derived complexes, e.g. fac-
[Pt(Me)3(N^N)I] 1, are luminescent, showing room temperature 
phosphorescence from excited states assigned as 3IL pi−pi*.1 The 
photochemistry of these units has been widely explored, with 
photo-reduction to the square-planar Pt(II) species typically 
observed,2 but there are few applications of Pt(IV)Me3 complexes in 
luminescence, while there is much data on cyclometallated Pt(II) 
complexes as lumophores. 3-5 
The analogous fac-[Re(CO)3(N^N)L] complexes are widely applied 
lumophores6 in which systematic variations in the (N^N) unit tune 
the absorption and emission characteristics, while variations in  L 
(usually substituted pyridines) control solubility and other physical 
characteristics.7 It is generally the case that substituted complexes, 
in which L is a nitrogen heterocycle, have attractive photophysical 
properties and stability while the precursor halido-complexes are 
unstable and tend to be toxic in biological work due to halide 
lability.8 Therefore, an investigation was undertaken of the 
synthesis and photophysical characteristics of a series of fac-
Pt(Me)3 complexes of chelating and monodentate ligands. Reaction 
of PtIMe3 with substituted bipyridines gave analogues of 1 with 
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Scheme 1 Synthesis of complexes 1-6 
electron donating (OMe, complex 2) and withdrawing (CO2Me, 
complex 3) groups in the 4,4’ positions (Scheme 1).
These complexes showed the respective blue- and red- shifted 
absorptions and emissions which would be predicted from the 
electronic structures (Table 1). Complexes of the general formula 
fac-[Pt(Me)3(bpy)L], where L is a substituted pyridine, were easily 
synthesised by the reaction of 1 with the appropriate pyridine in 
the presence of KPF6 to give complexes 4-6 (Scheme 1). However, 
the yellow colour of 1 had been lost, and while these complexes 
were luminescent (see Table 1) u.v. excitation was required. 
Reaction of 1 with triphenyl phosphine or aniline gave complexes 7
and 8, but these complexes too required u.v. excitation. As it 
seemed that substituting the iodide led to loss of the low energy 
band responsible for visible absorption and excitation, a re-
examination of the nature of this band was required. It is not clear 
why substitution of iodide for N- and P- donor ligands leads to 
complete loss of this transition, which has previously been assigned 
as a formally disallowed 3IL pi−pi* transition.1
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Table 1. Photophysical data of complexes 1-10. 
λ max 
absa 
λmax absb λmax
ex
λmax
em 
Θc
1 297, 308 344 380 530  
2 280, 289, 
299 
356 330 520  
3 314, 323 372 420 600  
4 300, 311 - 330 470
5 300, 310 - 333 470  
6 290, 300, 
310 
- 330 470  
7 304, 313 - 325 470 1.3*10-2
8 290, 298, 
310 
- 345 540 2.6*10-4
9 301, 308, 
358 
440 450 660 4.1*10-4
10 310, 350  500  490 560 3.7*10-4
a) Strongest bands >275 nm; b) Lowest energy band / shoulder; c) 
Relative to [Ru(bpy)3].2PF6 aerated solution, Θ=0.01817. 
Figure 1: Occupied (bottom) and unoccupied (top) orbitals of 1, 4, Pt(Me)3(bipy)SH 
and 9 involved in low energy absorption bands.
i) 1 or 3, NaOBut MeCN
i
9 R= H
10 R= CO2Me
SH
S
R
R N
N
Pt
MeO2C
CO2Me
Scheme 2. Synthesis of complexes 9 and 10. i) MeCN, NaO-t-Bu. 
We therefore carried out time-dependent density functional theory 
(TD-DFT)9-16 calculations on 1 and 4 to compare the absorption 
bands in these species in detail (see ESI for details). This predicts 
absorption bands for 1 at 358 and 294 nm, in reasonable agreement 
with the experimental values of 344, 308 and 297 nm. In contrast, 4
is predicted to absorb at 294 and 284 nm (experimental values 311 
and 300 nm). The band at 358 nm in 1 corresponds to excitation 
from an orbital made up largely of a Pt-I σ-bond, along with a lesser 
amount of trans- Pt-Me, to the pi* MO on bpy, as illustrated in 
Figure 1. Hence this low energy band is best described as Inter-
Ligand Charge Transfer rather than either 3IL pi-pi* or MLCT. ILCT 
between halogen and bipyridine antibonding orbitals is also seen 
admixed with MLCT in the analogous Re complexes,6 which 
occasionally may cause problems in biological studies  due to halide 
lability leading to interaction of the heavy metal centre with 
biomolecules (e.g. DNA).18 These results therefore call into question 
the literature assignment, but do explain the change in absorption 
patterns between 1 and 4, since the latter does not contain a low 
energy orbital of the correct symmetry to reproduce such 
absorption. They also suggest a strategy for combining the desirable 
properties of visible absorption and kinetic stability in [Pt(Me3)N^N 
L]+ complexes, i.e. to find L that combines a strong Pt-L bond with 
suitable electronic structure for interaction with bpy pi*. Thiols 
satisfy both requirements, so further TD-DFT calculations were 
performed for [Pt(Me3)(bpy)(SH)], from which we predict an 
absorption band at 393 nm corresponding to S lone pair/Pt-S σ-
bond to bpy pi* orbitals (Figure 1). 
Having obtained computational support for the hypothesis that 
thio-substituted complexes should show low energy absorption, 
methyl-4-mercaptobenzoate was selected as a model ligand which 
would (through variations of the ester) allow the incorporation of a 
variety of substituents at the sulphur ligand, giving the tuneable 
lipophilicity etc. which has proven important in the development of 
metallo-imaging agents. Treatment of 1 with a small excess of 
methyl-4-mercaptobenzoate in acetonitrile in the presence of 
sodium t-butoxide gave the thiobenzoatesubstituted complex 9
(Scheme 2: full data in ESI), and reaction with 3 gave the ester-
substituted analogue 10. Electronic spectroscopy confirmed that 9
exhibits low energy absorption, observed as a shoulder centred at 
440 nm, along with higher energy bands around 300 / 350 nm (TD-
DFT predicts absorption at 440 nm due to S LP*/S-Pt*, 
Figure 1). Luminescence spectroscopy indicated that the maximum 
excitation band was centred at ca. 450 nm, correlating with the 
likely true maximum of the band observed as a shoulder at 440 nm 
in the uv-vis spectrum. Exciting at 450 nm gave rise to intense 
emission as a broad band centred around 660 nm (Figure 2). 
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Figure 2 Excitation and emission spectra for 9 and 10.
Complex 9 is air- and water stable, resistant to ligand substitution of 
the coordinated thiolate under physiological conditions, and with 
visible excitation, a Stokes shift of over 200 nm and red emission is 
an ideal candidate for fluorescence imaging experiments. 
Complex 8 bearing electron withdrawing ester substituents was 
likewise converted to the methyl 4-mercaptobenzoate complex 10 
and showed a low energy absorption band centred at ca. 500 nm 
(DFT prediction 532 nm), and an excitation maximum at 490 nm, 
(Figure 2) confirming that the photophysics of these complexes is 
susceptible to significant variations accessible by ligand variations. 
However, unexpectedly the emission maximum of 10 was blue-
shifted in comparison to that of 9 indicating that simple 
assumptions regarding substituent effects can be misleading, 
especially in the case of emission from triplet states where the 
Stokes shift is a function of energy losses through relaxation into 
triplet geometries, the magnitude of which cannot be estimated 
intuitively from electron donating/withdrawing arguments. 
As a preliminary assessment of the potential for applications of 
complexes such as 9, a study of cellular uptake was undertaken by 
flow cytometry and fluorescence microscopy. This used the well 
characterised HeLa human cervical carcinoma cell line, and was 
performed at 0-4 °C to inhibit endocytosis. Flow cytometry 
detecting between 655-735 nm (Fig. 3, PerCP-Cy5.5) appeared to  
Figure 3 : Flow cytometric analysis of 9 uptake by HeLa cells; x-axis = fluorescence 
intensity, y-axis = counts. Flow cytometry histograms of gated cells treated with the 
indicated concentrations of 9 for 10 minutes are shown. The PerCP-Cy5.5 channel 
detects fluorescence between 655 and 735 nm and the PE-Cy7 channel detects 
fluorescence between 750 and 810 nm, excitation energy 13.01 mW.
Figure 4: Microscopy images of HeLa S3 cells treated with 9 at the indicated 
concentrations. Images show overlay of brightfield and confocal fluorescence 
(excitation 458 nm 30 mW  Ar laser 50% power output 16% transmission; emission 
longpass 560 nm filter) fields.
indicate little increase in fluorescence over background at < 125 
µg/mL, then a dramatic increase in uptake due to interference from 
autofluorescence at lower concentrations. However, taking 
advantage of the emission band of 9 which extends well into the 
NIR, detection between 750 and 810 nm (Fig. 3, PerCP-Cy7) clearly 
showed good uptake of 9 with a dose-dependent response with the 
number of cells showing enhanced intensity of emission increasing 
as a function of concentration.  
Confocal microscopy of HeLa S3 cells confirmed the dose-
dependent cellular uptake observed in the flow cytometry 
correlated with uptake in intact cells (Fig. 4). The luminescence 
from 9 formed a punctate pattern of discrete staining of 
compartments in the perinuclear region of the cytoplasm at 25 µg / 
mL, and at 125 µg / mL more generalised staining of the 
cytoplasmic region was observed. 9 was not designed with any of 
the features associated with a preference for localisation in a 
particular organelle, but is a prototype of this new class of 
lumophores, so it was pleasing that it appeared not to be retained 
in the plasma membrane but is capable of permeating the 
cytoplasm, which bodes well for the design of targeted imaging 
agents. While some deformations of the membrane surfaces were 
observed in confocal microscopy even at 25 µg, flow cytometry 
forward scatter and side scatter profiles indicate cells remained 
largely intact, even at 125 µg/ml (see ESI). The combination of NIR 
detection and the ability to penetrate the cell membrane without 
causing cell lysis is an indication that these complexes have promise 
as lumophores in cell imaging. While Pt(II) complexes have 
previously been applied in cellular imaging,19-21 and have a well-
established role in therapy,22 we believe this to be the first 
application of Pt(IV) species in fluorescence microscopy.23 The 
possibility of theranostic approaches with a Pt(IV) imaging agent of 
low cytotoxicity, which could be tailored through imaging studies to 
target organisms and organelles of interest, and reduced, or 
photoactivated, to a highly cytotoxic Pt(II) species is particularly 
interesting. 
In summary, complexes of the general structure 
[PtMe3(N^N)SR], where (N^N) represents a bisimine ligand 
such as 2,2’bipyridine, are visible absorbing, red or NIR 
emitting lumophores which are easily synthesised in a few 
steps from commercially available materials. DFT data indicate 
that absorption and excitation stems from promotion of an 
electron localised in the S-Pt bond into the pi* orbital on 
bipyridine. Absorption and emission profiles are therefore 
tuneable through simple ligand substitutions. Preliminary 
experiments show that biological applications as fluorescent 
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agents are possible with these complexes. The NIR emission 
can be used to differentiate agent-based emission from 
autofluorescence even at low levels of uptake and emission 
intensity. 
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